Cart (0 Items)
Your cart is currently empty.
View ProductsOpicinumab Biosimilar – Anti-LINGO1, LRRN6A, LERN1 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb - Research Grade |
|---|---|
| Source | CAS 1422268-07-2 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Opicinumab,BIIB-033,LINGO1, LRRN6A, LERN1,anti-LINGO1, LRRN6A, LERN1 |
| Reference | PX-TA1389 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb - Research Grade
General information on Anti-LINGO1/LRRN6A/LERN1[Homo sapiens] (Opicinumab) Monoclonal Antibody
Opcinumab is investigated for the treatment of Central Nervous System (CNS) Demyelinating Disease and Multiple Sclerosis.
SDS-PAGE for Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb
Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.